BIOMAT Database Logo BIOMAT Database Logo

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26. 2000

D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Centre d'Immunologie de Marseille Luminy, Institut National de la Santé et de la Recherche Médicale-Centre National de la Recherche Scientifique Case 906, Parc Scientifique de Luminy, 13288 Marseille Cedex 9, France.

A subset of prolyl oligopeptidases, including dipeptidyl-peptidase IV (DPP IV or CD26, EC ), specifically cleave off N-terminal dipeptides from substrates having proline or alanine in amino acid position 2. This enzyme activity has been implicated in the regulation of the biological activity of multiple hormones and chemokines, including the insulinotropic peptides glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). Targeted inactivation of the CD26 gene yielded healthy mice that have normal blood glucose levels in the fasted state, but reduced glycemic excursion after a glucose challenge. Levels of glucose-stimulated circulating insulin and the intact insulinotropic form of GLP-1 are increased in CD26(-/-) mice. A pharmacological inhibitor of DPP IV enzymatic activity improved glucose tolerance in wild-type, but not in CD26(-/-), mice. This inhibitor also improved glucose tolerance in GLP-1 receptor(-/-) mice, indicating that CD26 contributes to blood glucose regulation by controlling the activity of GLP-1 as well as additional substrates. These data reveal a critical role for CD26 in physiological glucose homeostasis, and establish it as a potential target for therapy in type II diabetes.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011498 Protein Precursors Precursors, Protein
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D000078790 Insulin Secretion Production and release of insulin from PANCREATIC BETA CELLS that primarily occurs in response to elevated BLOOD GLUCOSE levels. Secretion, Insulin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin).
September 1998, Biochemical and biophysical research communications,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Improved glucose tolerance via enhanced glucose-dependent insulin secretion in dipeptidyl peptidase IV-deficient Fischer rats.
June 2001, Biochemical and biophysical research communications,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice.
September 2000, European journal of pharmacology,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Impaired glucose-stimulated insulin secretion, enhanced intraperitoneal insulin tolerance, and increased beta-cell mass in mice lacking the p110gamma isoform of phosphoinositide 3-kinase.
September 2004, Endocrinology,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Enhanced insulin secretion and improved glucose tolerance in mice with homozygous inactivation of the Na(+)K(+)2Cl(-) co-transporter 1.
October 2012, The Journal of endocrinology,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Glucose tolerance and insulin secretion in neonatal and adult mice.
March 1971, Diabetes,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Insulin secretion and impaired glucose tolerance.
October 2010, Diabetologia,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
[Lipoproteins, glucose tolerance and insulin secretion].
January 1979, Annales de la nutrition et de l'alimentation,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Improved glucose homeostasis and enhanced insulin signalling in Grb14-deficient mice.
February 2004, The EMBO journal,
D Marguet, and L Baggio, and T Kobayashi, and A M Bernard, and M Pierres, and P F Nielsen, and U Ribel, and T Watanabe, and D J Drucker, and N Wagtmann
Insulin secretion and glucose tolerance in acromegaly.
January 1976, Endokrinologie,
Copied contents to your clipboard!